Related Experiment Video
Updated: May 2, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Therapy duration and long-term outcomes in extra-pulmonary tuberculosis
Tobias Pusch, Jotam G Pasipanodya, Ronald G Hall
1Department of Medicine, University of Texas Southwestern Medical Center, Dallas, USA. tawanda.gumbo@utsouthwestern.edu.
Extra-pulmonary tuberculosis (EPTB) outcomes vary significantly by type and are influenced by treatment duration. A "V" shaped relationship suggests that prolonged therapy may increase mortality risk in EPTB patients.
Area of Science:
- Infectious Diseases
- Public Health
- Epidemiology
Background:
- Tuberculosis is categorized into pulmonary and extra-pulmonary forms (EPTB).
- EPTB receives less research focus than pulmonary tuberculosis and is often considered a residual diagnosis.
- This study addresses the under-researched area of EPTB outcomes.
Purpose of the Study:
- To investigate the long-term mortality predictors in patients with extra-pulmonary tuberculosis (EPTB).
- To compare survival rates between different types of EPTB and latent tuberculosis.
- To identify factors influencing all-cause mortality in EPTB patients.
Main Methods:
- Retrospective cohort study of 438 EPTB patients in Texas (2000-2005).
- Data abstracted from tuberculosis case records and Social Security Administration Death Master File.
- Cox proportional hazard models and machine learning analyses used to determine mortality predictors.
Main Results:
- Significant predictors of mortality included age, treatment duration, EPTB type, and HIV infection.
- Meningitis had the highest mortality (46.2%), while genitourinary TB had outcomes similar to latent TB.
- A "V" shaped curve showed increased mortality with both shorter and longer treatment durations for specific EPTB types.
Conclusions:
- Extra-pulmonary tuberculosis encompasses diverse conditions with distinct prognoses.
- The observed "V" shaped therapy duration-mortality relationship suggests potential harm from extended treatment.
- Further research is needed to optimize EPTB treatment durations.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration